Molecular defects of the insulin receptor gene
1995; Wiley; Volume: 11; Issue: 1 Linguagem: Inglês
10.1002/dmr.5610110105
ISSN1099-0895
Autores Tópico(s)Diabetes Treatment and Management
ResumoDiabetes/Metabolism ReviewsVolume 11, Issue 1 p. 47-62 Article Molecular defects of the insulin receptor gene Domenico Accili MD, Corresponding Author Domenico Accili MD National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, U.S.A.Diabetes Branch, NIDDK, Building 10, Room 8N 244, Bethesda, MD 20892, U.S.A.Search for more papers by this author Domenico Accili MD, Corresponding Author Domenico Accili MD National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, U.S.A.Diabetes Branch, NIDDK, Building 10, Room 8N 244, Bethesda, MD 20892, U.S.A.Search for more papers by this author First published: April 1995 https://doi.org/10.1002/dmr.5610110105Citations: 25AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Kahn CR: Banting Lecture: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: 1066–1084, 1994. 2 Taylor SI, Accili D, and Imai Y: Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 43: 735–740, 1994. 3 Lander ES, Schork NJ: Genetic dissection of complex traits. Science 265: 2037–2048, 1994. 4 Taylor SI: Lilly Lecture: Molecular mechanisms of insulin resistance: lessons from patients with mutations in the insulin receptor gene. Diabetes 41: 1473–1490, 1991. 5 Bell GI, Froguel P, Nishi S, Pilkis SJ, Stoffel M, Takeda J, Vionnet N, and Yasuda K: Mutations of the human glucokinase gene and diabetes mellitus. Trends Endocrinol Metab 4: 86–91, 1993. 6 Cox NJ, Xiang KS, Fajans SS, and Bell GI: Mapping diabetes-susceptibility genes. Lessons learned from search for DNA marker for maturity-onset diabetes of the young. Diabetes 41: 401–417, 1992. 7 Spielman RS, and Nussbaum RL: Dual development in diabetes. Nature Genet 1: 82, 1992. 8 Reaven GM: Role of insulin resistance in human disease. Diabetes 37: 1595–1607, 1988. 9 Knowler WC, Pettitt DJ, Saad MF, and Bennett PH: Diabetes mellitus in Pima Indians: incidence, risk factors, and pathogenesis. Diabetes/Metab Rev 6: 1–27, 1990. 10 Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, and Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340: 925–929, 1992. 11 Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, and Roth J: The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med 294: 739–745, 1976. 12 Accili D, Frapier C, Mosthaf L, McKeon C, Elbein SC, Permutt MA, Ramos E, Lander E, Ullrich A, and Taylor SI: A mutation in the insulin receptor gene that impairs transport of the receptor to the plasma membrane and causes insulin resistant diabetes. EMBO J 8: 2509–2517, 1989. 13 Kadowaki T, Kadowaki H, Rechler MM, Serrano-Rios M, Roth J, Gorden P, and Taylor SI: Five mutant alleles of the insulin receptor gene in patients with genetic forms of insulin resistance. J Clin Invest 86: 254–264, 1990. 14 Taylor SI, Cama A, Accili D, Barbetti F, Quon MJ, Sierra M, Suzuki Y, Koller E, Levy-Toledano R, Wertheimer E, Moncada VY, Kadowaki H, and Kadowaki T: Mutations in the insulin receptor gene. Endocrine Rev 13: 566–595, 1992. 15 Cama A, Sierra ML, Ottini L, Kadowaki T, Gorden P, Imperato-McGinley J, and Taylor SI: A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman. J Clin Endocrinol Metab 73: 894–901, 1991. 16 Fradkin JE, Eastman RC, Lesniak MA, and Roth J: Specificity spillover at the hormone receptor—exploring its role in human disease. N Engl J Med 320: 640–645, 1989. 17 Imano E, Kadowaki H, Kadowaki T, Iwama N, Watarai T, Kawamori R, Kamada T, and Taylor SI: Two patients with insulin resistance due to decreased levels of insulin receptor mRNA. Diabetes 40: 548–557, 1991. 18 Rosenberg AM, Haworth JC, Degroot GW, Trevanen CL, and Rechler MM: A case of leprechaunism with severe hyperinsulinemia. Am J Dis Child 134: 170–175, 1980. 19 Suzuki Y, Hatanaka Y, Shimada F, Nozaki O, Takayanagi M, Makino H, and Yoshida S: Insulin resistance associated with decreased levels of insulin receptor mRNA. Diabetes 41 (Suppl 1): 90A (Abstract No. 325), 1992. 20 van der Vorm ER, van der Zon GCM, Möller W, Krans HMJ, Lindhout D, and Maassen JA: An Arg for Gly substitution at position 31 in the insulin receptor, linked to insulin resistance, inhibits receptor processing and transport. J Biol Chem 267: 66–71, 1992. 21 Wertheimer E, Lu SP, Backeljauw PF, Davenport ML, and Taylor SI: Homozygous deletion of the human insulin receptor gene. Nat Genet 5: 71–73, 1993. 22 Krook A, and O'Rahilly S: The role of insulin receptor gene mutations in syndromes of insulin resistance. Exp Clin Endocrinol 101 (Suppl 2): 308–309, 1993. 23 Hone J, Accili D, Psiachou H, Zadeh JA, Mitton S, Sinclair L, and Taylor SI: Homozygosity for a null allele of the insulin receptor gene in a patient with leprechaunism. J Med Genet (in press). 24 Jospe N, and Kaplowitz PB: Homozygous mutation in the insulin receptor β-subunit of a patient with leprechaunism altering arginine 786 to a stop codon. Abstracts of the 75th Annual Meeting of the Endocrine Society, p. 453 (Abstract No. 1609), 1993. 25 Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Taylor SI, Westphal H: Insulin receptor knock-out mice. Program and Abstracts of the 77 Meeting of the Endocrine Society, Washington, DC, June 1995, in press. 26 Rabson SM, and Mendenhall EN: Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetes mellitus. Am J Clin Pathol 26: 283–287, 1956. 27 Taylor SI, and Accili D: Insulin receptors: structure and function. Curr Opinion 1: Endocrinol Diab 231–238, 1994. 28 Seino S, Seino M, Nishi S, and Bell GI: Structure of the human insulin receptor gene and characterization of its promoter. Proc Natl Acad Sci USA 86: 114–118, 1989. 29 Yang-Feng TL, Francke U, and Ullrich A: Gene for human insulin receptor: localization to site on chromosome 19 involved in pre-B-cell leukemia. Science 228: 728–731, 1985. 30 Ullrich A, Bell JR, Chen EY, Herrera R, Petruzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M, Mason A, Seeburg PH, Grunfeld C, Rosen OM, and Ramachandran J: Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313: 756–761, 1985. 31 Ebina Y, Ellis L, Jarnagin K, Edery M, Graf L, Clauser E, Ou JH, Masiarz F, Kan YW, Goldfine ID, Roth RA, and Rutter WJ: The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 40: 747–757, 1985. 32 White MF, and Kahn CR: The insulin signalling system. J Biol Chem 269: 1–4, 1994. 33 Brown MS, and Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34–47, 1986. 34 Jospe N, Zhu R, Livingston JN, and Furlanetto RW: Heterozygous deletion of 3 base pairs resulting in the deletion of lysine 121 in the insulin receptor β-subunit from a patient with leprechaunism. Diabetes 42 (Suppl 1): 63A (Abstract No. 202), 1993. 35 Taira M, Taira M, Hashimoto N, Shimada F, Suzuki Y, Kanatsuka A, Nakamura F, Ebina Y, Tatibana M, Makino H, and Yoshida S: Human diabetes associated with a deletion of the tyrosine kinase domain of the insulin receptor. Science 245: 63–66, 1989. 36 Shimada F, Taira M, Suzuki Y, Hashimoto N, Nozaki O, Taira M, Tatibana M, Ebina Y, Tawata M, Onaya T, Makino H, and Yoshida S: Insulin-resistant diabetes associated with partial deletion of insulin-receptor gene. Lancet 335: 1179–1181, 1990. 37 Shimada F, Suzuki Y, Taira M, Hashimoto N, Nozaki O, Makino H, and Yoshida S: Abnormal messenger ribonucleic acid (mRNA) transcribed from a mutant insulin receptor gene in a patient with type A insulin resistance. Diabetologia 35: 639–644, 1992. 38 Kadowaki T, Bevins CL, Cama A, Ojamaa K, Marcus-Samuels B, Kadowaki H, Beitz L, McKeon C, and Taylor SI: Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 240: 787–781, 1988. 39 Kadowaki T, Kadowaki H, and Taylor SI: A nonsense mutation causing decreased levels of insulin receptor mRNA: detection by a simplified technique for direct sequencing of genomic DNA amplified by polymerase chain reaction. Proc Natl Acad Sci USA 87: 658–662, 1990. 40 Kusari J, Takata Y, Hatada E, Freidenberg G, Kolterman O, and Olefsky JM: Insulin resistance and diabetes due to different mutations in the tyrosine kinase domain of both insulin receptor gene alleles. J Biol Chem 266: 5260–5267, 1991. 41 Kadowaki T, Kadowaki H, Accili D, and Taylor SI.: Substitution of lysine for asparagine-15 in the human insulin receptor impairs intracellular transport of the receptor to the cell surface and decreases the affinity of insulin binding. J Biol Chem 265: 19143–19150, 1990. 42 Kadowaki T, Kadowaki H, Accili D, Yazaki Y, and Taylor SI: Substitution of arginine for histidine at position 209 in the α-subunit of the human insulin receptor. A mutation that impairs receptor dimerization and transport of receptors to the cell surface. J Biol Chem 266: 21224–21231, 1991. 43 Maassen JA, Van der Vorm ER, Van der Zon GCM, Klinkhamer MP, Krans HMJ, and Möller W: A leucine to proline mutation at position 233 in the insulin receptor inhibits cleavage of the proreceptor and transport to the cell surface. Biochemistry 30: 10778–10783, 1991. 44 Klinkhamer M, Groen NA, van der Zon GCM, Lindhout D, Sandkuyl LA, Krans HM, Möller W, and Maassen JA: A leucine-to-proline mutation in the insulin receptor in a family with insulin resistance. EMBO J 8: 2503–2508, 1989. 45 Kobayashi M, Sasaoka T, Takata Y, Hisatomi A, and Shigeta Y: Insulin resistance by uncleaved insulin proreceptors. Emergence of binding site by trypsin. Diabetes 37: 653–656, 1988. 46 Kakehi T, Hisatomi A, Kuzuya H, Yoshimasa Y, Okamoto M, Yamada K, Nishimura H, Kosaki A, Nawata H, Umeda F, Ibayashi H, and Imura H: Defective processing of insulin-receptor precursor in cultured lymphocytes from a patient with extreme insulin resistance. J Clin Invest 81: 2020–2022, 1988. 47 Barbetti F, Gejman PV, Taylor SI, Raben N, Cama A, Bonora E, Pizzo P, Moghetti P, Muggeo M, and Roth J: Detection of mutations in the insulin receptor gene by denaturing gradient gel electrophoresis. Diabetes 41: 408–415, 1992. 48 Wertheimer E, Barbetti F, Muggeo M, Roth J, and Taylor SI: Two mutations in a conserved structural motif in the insulin receptor inhibit normal folding and intracellular transport of the receptor. J Biol Chem 269: 7587–7592, 1994. 49 Carrera P, Cordera R, Ferrari M, Cremonesi L, Taramelli R, Andraghetti G, Carducci C, Dozio N, Pozza G, Taylor SI, Micossi P, and Barbetti F: Substitution of Leu for Pro-193 in the insulin receptor in a patient with a genetic form of severe insulin resistance. Hum Mol Genet 2: 1437–1441, 1993. 50 Hone J, Accili D, Al-Gazali LI, Lestringant G, Orban T, and Taylor SI: Homozygosity for a novel mutation (Ile119 Met) in the insulin receptor gene in five siblings with familial insulin resistance. J Med Genet 31: 715–716, 1994. 51 Longo N, Langley SD, Griffin LD, and Elsas LJ: Activation of glucose transport by a natural mutation in the human insulin receptor. Proc Natl Acad Sci USA 90: 60–64, 1993. 52 Kobayashi M, Sasaoka T, Takata Y, Hisatomi A, and Shigeta Y: Insulin resistance by unprocessed insulin proreceptors point mutation at the cleavage site. Biochem Biophys Res Commun 153: 657–663, 1988. 53 van der Vorm ER, Van der Zorn ZCM, Kielkopf-Renner S, Krans HMJ, Möller W, and Maassen JA: A mutation in the α-chain of the insulin receptor at codon 412 associated with decreased insulin binding and leprechaunism. Exp Clin Endocrinol 101 (Suppl 2): 357, 1993. 54 Takata Y, Egawa K, Iwanishi M, Imamura T, and Kobayashi M: Insulin resistance due to impaired processing of the mutant receptor (Leu193). Diabetes 42 (Suppl 1): 217 A (Abstract No. 693), 1993. 55 Cama A, Sierra M, Quon MJ, Ottini L, Gorden P, and Taylor SI: Substitution of glutamic acid for alanine 1135 in the putative catalytic loop of the tyrosine kinase domain of the human insulin receptor. A mutation that impairs proteolytic processing into subunits and inhibits receptor tyrosine kinase activity. J Biol Chem 268: 8060–8069, 1993. 56 Accili D, Kadowaki T, Kadowaki H, Mosthaf L, Ullrich A, and Taylor SI: Immunoglobulin heavy chain binding protein (BiP) binds to misfolded mutant insulin receptors with mutations in the extracellular domain. J Biol Chem 267: 586–590, 1992. 57 Pelham HRB: Control of protein exit from the endoplasmic reticulum. Annu Rev Cell Biol 5: 1–23, 1989. 58 Yang Y, Janich S, Cohn JA, and Wilson JM: The common variant of cystic fibrosis transmembrane conductance regulator is recognized by Hsp70 and degraded ina pre-Golgi nonlysosomal compartment. Proc Natl Acad Sci USA 90: 9480–9484, 1993. 59 Chessler SD, and Byers PH: BiP binds type I procollagen pro-alpha chains with mutations in the carboxyl-terminal propeptide synthesized by cells from patients with osteogenesis imperfecta. J Biol Chem 268: 18226–18234, 1993. 60 Bajaj M, Waterfield MD, Schlessinger J, Taylor WR, and Blundell T: Receptor-mediated internalization of insulin requires a 12-amino acid sequence in the juxtamembrane region of the insulin receptor beta-subunit. Biochim Biophys Acta 916: 220–226, 1987. 61 Levy-Toledano R, Caro LHP, Accili D, and Taylor SI: Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor. EMBO J 13: 835–842, 1994. 62 Andersen AS, Kjeldsen T, Wiberg FC, Christensen PM, Rasmussen JS, Norris K, Moller KB, and Moller NPH: Changing the insulin receptor to possess insulin-like growth factor I ligand specificity. Biochemistry 29: 7363–7366, 1990. 63 Kjeldsen T, Andersen AS, Wiberg FC, Rasmussen JS, Schaffer L, Balschmidt P, Moller KB, and Moller NP: The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site. Proc Natl Acad Sci USA 88: 4404–4408, 1991. 64 Gustafson TA, and Rutter WJ: The cysteinerich domains of the insulin and insulinlike growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras. J Biol Chem 265: 18663–18667, 1990. 65 Schaefer EM, Siddle K, and Ellis L: Deletion analysis of the human; insulin receptor ectodomain reveals independently folded soluble subdomains and insulin binding by a monomelic a-subunit. J Biol Chem 265: 13248–13253, 1990. 66 Zhang B, and Roth RA: Binding properties of chimeric insulin receptors containing the cysteine-rich domain of either the insulin-like growth factor I receptor or the insulin receptor related receptor. Biochemistry 30: 5113–5117, 1991. 67 Zhang B, and Roth RA: A region of the insulin receptor important for ligand binding (residues 450–601) is recognized by patients' autoimmune antibodies and inhibitory monoclonal antibodies. Proc Natl Acad Sci USA 88: 9858–9862, 1991. 68 Schumacher R, Mosthaf L, Schlessinger J, Brandenburg D, and Ullrich A: Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors. J Biol Chem 266: 19288–19295, 1991. 69 Yoshimasa Y, Paul JI, Whittaker J, and Steiner DF: Effects of amino acid replacements within the tetrabasic cleavage site on the processing of the human insulin receptor precursor expressed in Chinese hamster ovary cells. J Biol Chem 265: 17230–17237, 1990. 70 Williams JF, McCIain DA, Dull TJ, Ullrich A, and Olefsky JM: Characterization of an insulin receptor mutant lacking the subunit processing site. J Biol Chem 265: 8463–8469, 1990. 71 Accili D, Mosthaf L, Levy-Toledano R, Ullrich A, and Taylor SI: Mutagenesis of Phe381–Phe382 in the a-subunit of the insulin receptor: effects on receptor biosynthesis, processing, and internalization. FEBS Lett 341: 104–108, 1994. 72 Roach P, Zick Y, Formisano P, Accili D, Taylor SI, and Gorden P: A novel human insulin receptor gene mutation uniquely inhibits insulin binding without impairing post-trans-lational processing. Diabetes 43: 1096–1102, 1994. 73 Gronskov K, Vissing H, Shymko RM, Tornqvist H, and De Meyts P: Mutation of arginine 86 to proline in the insulin receptor alpha subunit causes lack of transport of the receptor to the plasma membrane, loss of binding affinity and a constitutively activated tyrosine kinase in transfected cells. Biochem Biophys Res Commun 192: 905–911, 1993. 74 Taouis M, Levy-Toledano R, Roach P, Taylor SI, and Gorden P: Structural basis by which a recessive mutation in the alpha-subunit of the insulin receptor affects insulin binding. J Biol Chem 269: 14912–14918, 1994. 75 Knighton DR, Cadena DL, Zheng J, Ten Eyck LF, Taylor SS, Sowadski JM, and Gill GN: Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor. Proc Natl Acad Sci USA 90: 5001–5005, 1993. 76 Odawara M, Kadowaki T, Yamamoto R, Shibasaki Y, Tobe K, Accili D, Bevins C, Mikami Y, Matsuura N, Akanuma Y, Takaku F, Taylor SI, and Kasuga M: Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor. Science 245: 66–68, 1989. 77 Yamamoto-Honda R, Kadowaki T, Momomura K, Tobe K, Tamori Y, Shibasaki Y, Mori Y, Kaburagi Y, Koshio O, Akanuma Y, Yazaki Y, and Kasuga M: Normal insulin receptor substrare-1 phosphorylation in autophos-phorylation-defective truncated insulin receptor. Evidence that phosphorylation of substrates might be sufficient for certain biological effects evoked by insulin. J Biol Chem 268: 16859–16865, 1993. 78 Hanks SK, Quinn AM, and Hunter T: The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241: 42–52, 1988. 79 Cama A, de la Luz Sierra M, Quon MJ, Ottini L, Gorden P, and Taylor SI: Substitution of glutamic acid for alanine at position 1135 in the catalytic loop of the tyrosine kinase domain of the human insulin receptor. A mutation that impairs proteolytic processing into subunits and inhibits receptor tyrosine kinase activity. J Biol Chem 268: 8060–8069, 1993. 80 Kishimoto M, Hashiramoto M, Yonezawa K, Shii K, Kazumi T, and Kasuga M: Substitution of glutamine for arginine 1131. A newly identified mutation in the catalytic loop of the tyrosine kinase domain of the human insulin receptor. J Biol Chem 269: 11349–11355, 1994. 81 Moller DE, Cohen O, Yamaguchi Y, Assiz R, Grigorescu F, Eberle A, Morrow LA, Moses AC, and Fliers JS: Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes 43: 247–255, 1994. 82 Kim H, Kadowaki H, Sakura H, Odawara M, Momomura K, Takahashi Y, Miyazaki Y, Ohtani T, Akanuma Y, Yazaki Y, Kasuga M, Taylor SI, and Kadowaki T: Detection of mutations in the insulin receptor gene in patients with insulin resistance by analysis of single stranded conformational polymorphisms. Diabetologia 35: 261–266, 1992. 83 Imamura T, Takata Y, Iwanishi M, and Kobayashi M: A kinase defective insulin receptor (Asp1179) causes decreased number of receptors in a patient with type A extreme insulin resistant syndrome. Diabetes 42 (Suppl 1): 218A (Abstract No. 698), 1993. 84 O'Rahilly S, Choi WH, Patel P, Turner RC, Flier JS, and Moller DE: Detection of mutations in insulin-receptor gene in NIDDM patients by analysis of single-stranded conformation polymorphisms. Diabetes 40: 777–782, 1991. 85 Takahashi Y, Kadowaki H, Momomura K, Odawara J, Orban T, Fukushima Y, and Kadowaki T: Identification of a homozygous mutation of the insulin receptor gene decreasing tyrosine kinase activity in a patient with leprechaunism. Diabetes 42 (Suppl 1): 63A (Abstract No. 203), 1993. 86 Cama A, Quon MJ, Sierra ML, and Taylor SI: Substitution of isoleucine for methionine at position 1153 in the β-subunit of the human insulin receptor, J Biol Chem 267: 8383–8389, 1992. 87 Formisano P, DeNovellis G, Miele C, Tripodi F, Caruso M, Palumbo G, Beguinot L, and Beguinot F: Internalization of the constitutively active arginine 1152 glutamine insulin receptor occurs independently of insulin at an accelerated rate. J Biol Chem 269: 16242–16246, 1994. 88 Iwanishi M, Haruta T, Takata Y, Ishibashi O, Sasaoka T, Egawa K, Imamura T, Naitou K, Itazu T, and Kobayashi M: A mutation (Trp1193 Leu1193) in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance. Diabetologia 36: 414–422, 1993. 89 Moller DE, Yokota A, Ginsberg-Fellner F, and Elier JS: Functional properties of a naturally occurring Trp1200–Ser1200 mutation of the insulin receptor. Mol Endocrinol 4: 1183–1191, 1990. 90 Kadowaki T, Kadowaki H, Ando A, Kaburagi Y, Quin JD, MacCuish A, Taylor SI, Yazaki Y, and Kasuga M: Two mutant alleles of the insulin receptor gene in insulin resistant patients. Program and Abstracts of the 73rd Annual Meeting of the Endocrine Society, p. 310 (Abstract No. 1119), 1991. 91 Kusari J, Takata Y, Hatada E, Freidenberg G, Kolterman O, and Olefsky JM: Insulin resistance and diabetes due to different mutations in the tyrosine kinase domain of both insulin receptor gene alleles. J Biol Chem 266: 5260–5267, 1991. 92 Maegawa H, McClain DA, Freidenberg G, Olefsky JM, Napier M, Lipart T, Dull TJ, Lee J, and Ullrich A: Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signalling metabolic events. J Siol Chem 263: 8912–8917, 1988. 93 Myers MG, Backer JM, Siddle K, and White MF: The insulin receptor functions normally in Chinese hamster ovary cells after truncation of the C terminus. J Biol Chem 266: 10616–10623, 1991. 94 Accili D, and Taylor SI: Targeted inactivation of the insulin receptor gene in mouse 3T3-L1 cells via homologous recombination. Proc Natl Acad Sci USA 88: 4708–4712, 1991. 95 Treadway JL, Morrison BD, Soos MA, Siddle K, Olefsky J, Ullrich A, McClain DA, and Pessin JE: Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors. Proc Natl Acad Sci USA 88: 214–218, 1991. 96 Frattali AL, Treadway JL, and Pessin JE: Transmembrane signalling by the human insulin receptor kinase. Relationship between intra-molecualr beta-subunit trans- and cis-autophos-phorylation and substrate kinase activation. J Biol Chem 267: 19521–19528, 1992. 97 Maegawa H, Olefsky JM, Thies S, Boyd D, Ullrich A, and McClain DA: Insulin receptors with defective tyrosine kinase inhibit normal receptor function at the level of substrate phosphorylation. J Biol Chem 263: 12629–12637, 1988. 98 Accili D, Mosthaf L, Ullrich A, and Taylor SI: A mutation in the extracellular domain of the insulin receptor impairs the ability of insulin to stimulate receptor autophosphorylation. J Biol Chem 266: 434–439, 1991. 99 Sierra ML, Cama A, Kadowaki T, Kadowaki H, Quon MJ, and Taylor SI: Two mutant alleles of the insulin receptor gene in a family with a genetic form of insulin resistance. Clin Res 41: 131A, 1993. 100 Cama A, Patterson A, Kadowaki T, Siegel G, D'Ambrosio D, Lillioja S, Roth J, and Taylor SI: Cloning of insulin receptor cDNA from an insulin resistant Pima Indian. J Clin Endocrinol Metab 70: 1155–1161, 1990. 101 Moller DE, Yokota A, and Flier JS: Normal insulin-receptor cDNA sequence in Pima Indians with NIDDM. Diabetes 38: 1496–1500, 1989. 102 Kusari J, Verma US, Buse JB, Henry RR, and Olefsky JM: Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus. J Clin Invest 88: 1323–1330, 1991. 103 Cocozza S, Porcellini A, Riccardi G, Monticelli A, Condorelli GL, Ferrara A, Pianese L, Miele C, Capaldo B, Beguinot F, and Varrone S: Non-insulin-dependent diabetes associated with mutation of kinase domain of the insulin receptor. Diabetes 41: 521–526, 1992. 104 McKeon C, and Pham T: Transactivation of the human insulin receptor gene by the CAAT/enhancer binding protein. Biochem Biophys Res Commun 174: 721–728, 1991. 105 Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, and Pedersen O: Amino acid polymorphisms of insulin receptor substrate-1 (IRS-1) in non-insulin-dependent diabetes mellitus. Lancet 342: 828–832, 1993. 106 Imai Y, Fusco A, Suzuki Y, Lesniak MA, D'Alfonso R, Sesti G, Bertoli A, Lauro R, Accili D, and Taylor SI: Variant sequences of insulin receptor substrate-1 in patients with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 79: 1655–1658, 1994. 107 Hager J, Zouali H, Velho G, and Froguel P: Insulin receptor substrate-1 (IRS-1) gene polymorphisms in French NIDDM families. Lancet 342: 1430, 1993. 108 Rossini AA: Lipoatrophic diabetes. In Joslin's Diabetes Mellitus, A Marble, LP Krall, RF Bradley, AR Christlieb, and JS Soeldner, Eds. Lea and Febiger, Philadelphia, 1985, pp. 834–842. 109 Dunaif A: Diabetes mellitus and polycystic ovary syndrome. In Polycystic Ovary Syndrome, A Dunaif, JR Givens, FP Haseltine, and GR Merriam, Eds. Blackwell, Cambridge, MA, 1992, pp. 347–358. 110 Fajans SS: Maturity-onset diabetes of the young (MODY). Diabetes/Metab Rev 5: 579–606, 1989. 111 Bell GI, Xiang KS, Newman MV, Wu SH, Wright LG, Fajans SS, Spielman RS, and Cox NJ: Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci USA 88: 1484–1488, 1991. Citing Literature Volume11, Issue1April 1995Pages 47-62 ReferencesRelatedInformation
Referência(s)